WU Superior Products Stock (OTC:WBWB), Trade Ideas

WU BA Superior Products Holding Group Inc Inc is operating in the new retail e-commerce business sector in the People's Republic of China. Its business is an e-commerce platform which offers marketplace services that enable third-party merchants to sell their products to consumers in China.

News

Intraday Update

Markets

Movers

Trading Ideas

ACDSF

ACGL

ADPT

ARES

ASML

ASMLF

ASMVY

ATUS

BCHEY

BEPTF

BF-A

BF-B

BXRDF

CABO

CACI

CASH

CCMP

CHTR

CIBEY

CLCT

COLD

CPRT

CRGE

DENN

DNKN

ELPVY

EPGG

EPRT

ESCU

FNLIF

FUNC

GATGF

GCEI

GGRN

GLDLF

GNRC

GROW

GRYN

HEBT

HELE

HLNE

HTLD

IMOS

INFO

JBSAY

JBSS

JRONY

KBAL

KLAC

KNSL

KNYJY

LBCMF

LBRDA

LBRDK

LDOS

LNSTY

LPCN

LUNA

MDLZ

MISVF

MKTX

NXTC

NXTN

OCPNY

OLED

OPRA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

Stocks That Hit 52-Week Highs On Thursday

WU BA SUPERIOR PRODUCTS by WU BA Superior Products Holding Group Inc.

WU BA Superior Products Holding Group Inc

WIIM

Community Health Systems shares are trading higher after the company reported better-than-expected Q1 financial results.

Shares of Teradyne, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) rose sharply in today's pre-market trading after the company posted upbeat first-quarter results and issued strong <a href="https://www.benzinga.com/quote/TER/earnings">second-quarter forecast</a>.
Teradyne posted adjusted earnings of 51 cents per share, beating market estimates of 33 cents per share. The company's quarterly sales came in at $599.819 million versus expectations of $566.310 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Teradyne shares jumped 8.4% to $109.20 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Intelligent Living Application Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) shares gained 57.3% to $0.8496 in pre-market trading after gaining over 12% on Wednesday.</li>
<li>reAlpha Tech Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) gained 31.8% to $1.53 in pre-market trading after jumping 93% on Wednesday.</li>
<li>Nuwellis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) climbed 25.9% to $0.3174 in pre-market trading after dipping 15% on Wednesday.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) gained 23% to $15.11 in pre-market trading after the company announced the divestiture of rezafungin to Mundipharma&#x2A;, reacquired global development and commercial rights to CD388 and announced $240 million in private placement financing.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) rose 15.4% to $5.56 in today's pre-market trading after the company reported results of Anktiva combined with checkpoint inhibitors in non-small cell lung cancer.</li>
<li>Hitek Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKIT#NASDAQ">HKIT</a>) shares gained 13.3% to $1.53 in pre-market trading.</li>
<li>Serve Robotics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) shares gained 9.6% to $3.09 in pre-market trading after dipping 11% on Wednesday.</li>
<li>Ascent Solar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) shares rose 9.1% to $0.099 in pre-market trading after falling 11% on Wednesday.</li>
<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) shares rose 9.1% to $13.38 in pre-market trading following upbeat quarterly results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Biophytis S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTS#NASDAQ">BPTS</a>) fell 36% to $6.08 in pre-market trading. Biophytis announced transfer of ADSs to OTC Market.</li>
<li>Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSSE#NASDAQ">CSSE</a>) declined 22.2% to $0.3307 in pre-market trading. Chicken Soup For The Soul Entertainment received delinquency letter from the Nasdaq.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) fell 18.7% to $3.21 in pre-market trading after dipping 15% on Wednesday.</li>
<li>ESGL Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESGL#NASDAQ">ESGL</a>) shares fell 14.5% to $0.54 in pre-market trading.</li>
<li>iSun, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISUN#NASDAQ">ISUN</a>) fell 13.5% to $0.0812 in pre-market trading. iSun shares dipped 38% on Wednesday after the company announced a reverse stock split.</li>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) shares declined 12.9% to $429.25 in pre-market trading after reporting first-quarter results.</li>
<li>BranchOut Food Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOF#NASDAQ">BOF</a>) fell 10.1% to $1.87 pre-market trading. BranchOut Food shares jumped 82% on Wednesday after the company announced it has expanded its existing relationship with the nation&#8217;s largest retailer, which brings the total annualized value of commitments from the retailer to over $8 million.</li>
<li>International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) fell 8.4% to $168.73 in pre-market trading after the company reported mixed first-quarter financial results. The company also announced it will acquire HashiCorp.</li>
<li>Vista Energy, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIST#NYSE">VIST</a>) shares fell 8.3% to $39.80 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
<li>Snap Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) fell 5% to $10.53 pre-market trading.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/04/38402120/top-3-industrials-stocks-that-are-set-to-fly-in-april">Top 3 Industrials Stocks That Are Set To Fly In April</a>

Pre-Market Outlook

AIRE

ASTI

BPTS

CDTX

CSSE

ESGL

HKIT

IBRX

ILAG

ISUN

NUWE

SERV

SNAP

VIST

ZAPP

Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) reported quarterly earnings of $0.17 per share which beat the analyst consensus estimate of $0.12 by 41.67 percent. This is a 13.33 percent increase over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $4.14 billion which missed the analyst consensus estimate of $4.19 billion by 1.24 percent. This is a 2.53 percent increase over sales of $4.04 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Cemex Q1 EPS $0.17 Beats $0.12 Estimate, Sales $4.14B Miss $4.19B Estimate

<div>Expects to deliver adjusted operating margin of&nbsp;22.5%&nbsp;-&nbsp;23.5%&nbsp;for the full year 2024,&nbsp;approximately&nbsp;$88 million&nbsp;in non-cash pension income for the full year 2024</div>

Guidance

Willis Towers Watson Still Expects To Deliver 2024 Revenue Of $9.9B Or Greater (Est $10.024B) And Mid-Single Digit Organic Revenue Growth, Adjusted EPS Of $15.40-$17.00 (Est $16.28)

<div>Revenue less repair payments&#x2A; is expected to be between&nbsp;$1,293&nbsp;million and&nbsp;$1,357&nbsp;million, up from&nbsp;$1,284.3&nbsp;million in fiscal 2024.&nbsp;Guidance&nbsp;assumes an average GBP to USD exchange rate of 1.27 versus 1.26 in fiscal 2024. ANI&#x2A; is expected to range between&nbsp;$206 million&nbsp;and&nbsp;$218 million&nbsp;versus&nbsp;$217.0 million&nbsp;in fiscal 2024.&nbsp;Guidance&nbsp;assumes an average USD to INR exchange rate of 83.0 versus 82.8 in fiscal 2024. Based on a diluted share count of 47.5 million shares, the company expects fiscal 2025 adjusted diluted earnings per share&#x2A; to be in the range of&nbsp;$4.34&nbsp;to&nbsp;$4.59&nbsp;versus&nbsp;$4.38&nbsp;in fiscal 2024.</div>
&quot;The company has provided our initial forecast for fiscal 2025 based on current visibility levels and exchange rates,&quot; said Sanjay Puria, WNS&#39; Chief Financial Officer. &quot;Our&nbsp;guidance&nbsp;for the full year reflects growth in revenue less repair payments&#x2A; of&nbsp;1%&nbsp;to&nbsp;6%&nbsp;on a reported&#x2A; basis, and&nbsp;0%&nbsp;to&nbsp;5%&nbsp;on a constant currency&#x2A; basis. For the year, we continue to expect capital expenditures of up to&nbsp;$65 million.&quot;

WNS (Holdings) Says It Expects FY25 Revenue Of $1.293B-$1.357B Vs. $1.36B Estimate; Projects FY25 Adjusted EPS Of $4.34-$4.59 Vs $4.54 Estimate

Xcel Energy Reaffirms FY24 EPS Guidance Of $3.50 - $3.60 Vs. $3.57 Estimate

Xcel Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.80 by 10 percent. The company reported quarterly sales of $3.649 billion which missed the analyst consensus estimate of $4.128 billion by 11.61 percent. This is a 10.56 percent decrease over sales of $4.080 billion the same period last year.

Xcel Energy Q1 2024 GAAP EPS $0.88 Beats $0.80 Estimate, Sales $3.649B Miss $4.128B Estimate

Ford Motor Company shares are trading higher after the company reported better-than-expected Q1 financial results.

EQNR

Equinor shares are trading higher following better-than-expected Q1 financial results.

Health Care

General

West Pharmaceutical Services Raises Full-year 2024 Adjusted EPS Guidance To $7.63-$7.88, Compared Prior Range Of $7.50-$7.75 Versus Consensus Of $7.63

Sanofi shares are trading higher following better-than-expected Q1 financial results.

AstraZeneca shares are trading higher following a Q1 revenue beat.

TABLE 1: FULL-YEAR 2024 GUIDANCE2
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
Previous Guidance
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
Current Guidance
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Sales
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$38.1B - $38.9B
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$38.1B - $38.9B
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Organic1 Growth
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
4% - 6%
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
4% - 6%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Segment Margin
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
23.0% - 23.3%
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
23.0% - 23.3%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Expansion
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
Up 30 - 60 bps
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
Up 30 - 60 bps
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted Earnings Per Share3
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$9.80 - $10.10
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$9.80 - $10.10
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Adjusted Earnings Growth3
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
7% - 10%
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
7% - 10%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Operating Cash Flow
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$6.7B - $7.1B
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$6.7B - $7.1B
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Free Cash Flow1
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$5.6B - $6.0B
</td>
<td colspan="1" rowspan="1">
			&nbsp;</td>
<td colspan="1" rowspan="1">
$5.6B - $6.0B
</td>
</tr>
</tbody>
</table>

Honeywell Reiterates FY2024 Outlook: Adj EPS $9.80-10.10 vs $9.95 Est; Sees Sales $38.100B-38.900B vs $38.48B Est

Unilever shares are trading higher following Q1 earnings.

Southside Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBSI#NASDAQ">SBSI</a>) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.68 by 4.41 percent. This is a 14.46 percent decrease over earnings of $0.83 per share from the same period last year. The company reported quarterly sales of $63.072 million which missed the analyst consensus estimate of $67.725 million by 6.87 percent. This is a 3.54 percent decrease over sales of $65.386 million the same period last year.

SBSI

Southside Bancshares Q1 2024 GAAP EPS $0.71 Beats $0.68 Estimate, Sales $63.072M Miss $67.725M Estimate

Sanjay will remain with WNS in an advisory role until April 24, 2025 to help ensure a seamless transition.

Management

WNS Names Arijit Sen, Its Corporate Financial Controller, As CFO Effective July 25, 2024, Succeeding Sanjay Puria Who Has Chosen To Step Down For Family Reasons

West Pharmaceutical Services Reaffirms Full-Year 2024 Net Sales Guidance Of $3B-$3.025B Versus Consensus Of $3.01B

Tri Pointe Homes Sees Q2 Deliveries 1,500-1,600 Homes At Avg. Sales Price $670K-$680K

Oshkosh Raises FY24 Adj. EPS Outlook To Be In The Range Of $11.25 vs $10.36 Est.

FirstCash Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCFS#NASDAQ">FCFS</a>) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.52 by 1.97 percent. This is a 24 percent increase over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $836.370 million which missed the analyst consensus estimate of $846.074 million by 1.15 percent. This is a 9.65 percent increase over sales of $762.739 million the same period last year.

FCFS

FirstCash Hldgs Q1 2024 Adj EPS $1.55 Beats $1.52 Estimate, Sales $836.370M Miss $846.074M Estimate

WU Superior Products